Correlation Between Opthea and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Opthea and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Protagenic Therapeutics, you can compare the effects of market volatilities on Opthea and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Protagenic Therapeutics.
Diversification Opportunities for Opthea and Protagenic Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Opthea and Protagenic is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Opthea i.e., Opthea and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Opthea and Protagenic Therapeutics
Considering the 90-day investment horizon Opthea is expected to generate 0.4 times more return on investment than Protagenic Therapeutics. However, Opthea is 2.53 times less risky than Protagenic Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 421.00 in Opthea on September 4, 2024 and sell it today you would lose (50.00) from holding Opthea or give up 11.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opthea vs. Protagenic Therapeutics
Performance |
| Timeline |
| Opthea |
| Protagenic Therapeutics |
Opthea and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opthea and Protagenic Therapeutics
The main advantage of trading using opposite Opthea and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |